Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow & tDCS Evidence

Woodham, R.D., Selvaraj, S., Lajmi, N. et al.

Oct, 2024

A ten-week double-blinded randomised control trial to evaluate the effectiveness and tolerability of the Flow tDCS device with an additional ten-week follow-up.

Griffiths, C., da Silva, K. M., Mobee-Dumi, A., Gill, A. K., & Ibrahim, D.

May, 2025

Transcranial Direct Current Stimulation (tDCS) and Online Wellbeing Training Used at Home for Perinatal and Maternal Loss Patients with a Diagnosis of Depression: Depression, Real World-Functioning, and Quality of Life Outcomes

Silva, K., Griffiths, C., Banazadeh, A. and Mu, M.

Apr, 2025

Transcranial Direct Current Stimulation (tDCS) Used at Home for People with a Diagnosis of Depression: Sleep Quality Outcomes

Griffiths, C., McIlhiney, W., Evans, A., O’Neill-Kerr, A., et al.

Nov, 2024

Impact of Flow tDCS for Depression Treatment in a Community Mental Health Team Service: Depression, Functioning, and Health-Related Quality of Life Outcomes

Griffiths, C., Abdalla, S., Mcconnochie, M., Jiang, H.

Nov, 2024

Impact of Self-Administered Flow tDCS Depression Treatment in a Crisis Resolution & Home Treatment Service: Functioning and Health-Related Quality of Life Outcomes

Griffiths, C., McIlhiney, W., O’Neill-Kerr, A., Walker, K., and Stringer

Aug, 2024

Feasibility and impact review of at-home Flow treatment for CMHT patients

Griffiths, C., Jiang, H., Smart, D., Zafar, A.

Jul, 2024

Flow tDCS can effectively and efficiently be delivered through a primary healthcare general practice service and patients will choose to use. The widespread availability of tDCS in primary care general practice should be considered.

Baukaite, E., Noel-Johnson, A., Walker, K., Griffiths, C.

Jun, 2024

Experiences and Value of Flow; Used at Home for Specialist Perinatal Mental Health Service and Maternal Loss Psychology Service Patients with Depression

Griffiths, C., Maravic da Silva, K., Jiang, H., Smart, D., and Zafar, A.

May, 2024

Flow for Depression Treatment in a Primary Healthcare General Practice—Depression, Functioning, and Health-Related Quality of Life Outcomes

Griffiths, C. , Walker, K. , Willis, A.

Feb, 2024

Qualitative Study Exploring the Experience and Value of Flow - Community Mental Health

Griffiths, C. , Walker, K. , Jiang, H. , Noel-Johnson, A. and Zafar, A.

Nov, 2023

Qualitative Study Exploring the Experience and Value of Flow - Primary Care

Additional studies showcasing Flow

Woodham et al.

Nov, 2023

Home-based tDCS is a potential first line treatment for MDD that is acceptable and safe

Sobral et al.

Oct, 2022

Using Flow home-based tDCS in clinical practice; case series

Woodham et al.

Sep, 2022

Is Flow a potential first line of treatment for depression?

Rimmer et al.

May, 2022

Participants in open-label trial “would very strongly recommend” Flow

Borrione et al.

Apr, 2021

Open label study showed substantial improvements in 80% of participants

Borrione et al.

Sep, 2020

Computational modeling of the Flow headset stimulation parameters and montage

Additional studies reviewing tDCS

Nikolin et al.

Mar, 2023

tDCS antidepressant effects peak at around 6 weeks

Frengi et al.

Jul, 2020

tDCS for depression is definitely effective (level A evidence)

Moffa et al.

Apr, 2020

A meta-analysis: tDCS was an effective intervention in reducing depressive symptoms

Razza et al.

Apr, 2020

An analysis of 23 clinical trials with 1092 patients, showing that tDCS is superior to placebo/sham

Chhabra et al.

Apr, 2020

Side effects from tDCS are mild, transient and well-tolerated

Sharafi et al.

Jul, 2019

tDCS is efficient in cases where antidepressants don’t work

Wang et al.

Jun, 2019

A meta-analysis: the intervention of tDCS was superior to the use of sham tDCS

Mutz et al.

Mar, 2019

tDCS was found to be efficacious and comparable to TMS

Pavlova et al.

Dec, 2017

30-minute tDCS sessions lead to better outcomes than 20-minutes sessions

Bikson et al.

Oct, 2017

Low-energy brain stimulation is safe to use

Brunoni et al.

Jun, 2017

Study including 245 patients, comparing tDCS with a common antidepressant

Bikson et al.

Jun, 2016

No serious adverse events were found across 33,200 tDCS sessions with 1000 users

Valiengo et al.

Apr, 2013

tDCS is a safe long-term follow-up treatment

Brunoni et al.

Apr, 2013

Combining tDCS and a common antidepressant increases the efficacy of each treatment

Loo et al.

Jan, 2012

tDCS is safe and effective for treating depression